To determine whether HBOT could prevent or at least ameliorate SCA-induced cellular loss in the hippocampal DG granule neurons, we performed immunofluorescence staining with neuronal marker NeuN. The gene discussed is RBFOX3; the disease is autosomal dominant cerebellar ataxia.